metformin and nutlin-3a

metformin has been researched along with nutlin-3a in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Apontes, P; Blagosklonny, MV; Demidenko, ZN; Leontieva, OV; Li, F1
Hiroshima, K; Morinaga, T; Namiki, T; Sekine, I; Shimada, H; Shimazu, K; Shingyoji, M; Tada, Y; Tagawa, M; Tatsumi, K1

Other Studies

2 other study(ies) available for metformin and nutlin-3a

ArticleYear
Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture.
    Oncotarget, 2011, Volume: 2, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Cytoprotection; Epithelial Cells; Fibroblasts; G1 Phase; Humans; Imidazoles; Metformin; Nocodazole; Paclitaxel; Piperazines; Sirolimus; Tumor Suppressor Protein p53

2011
Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways.
    BMC cancer, 2017, 05-02, Volume: 17, Issue:1

    Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Imidazoles; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Metformin; Piperazines; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53

2017